Canaccord Genuity Reiterates a 'Buy' on Stryker (SYK); New Hip Product Cycle Drives Recon Stabilization; MedSurg Keeps Chugging
Go back to Canaccord Genuity Reiterates a 'Buy' on Stryker (SYK); New Hip Product Cycle Drives Recon Stabilization; MedSurg Keeps Chugging| Stryker Corp. (NYSE: SYK) | Delayed: 338.25 -1.73 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $339.98 | 52 Week High | $123.55 | |||
| Open | $338.26 | 52 Week Low | $86.68 | |||
| Day High | $342.35 | P/E | 128.61 | |||
| Day Low | $336.89 | EPS | $2.63 | |||
| Volume | 480,463 | |||||

